ILLUMINA INC (ILMN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ILMN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ILMN | Board Chair at MIT The Engine; Director | 65 | ["Board Director at Align Technology","Board Director at the Kaiser Family Foundation","Senior Lecturer at MIT Sloan School of Management","Extensive experience leading and growing life science companies","Driving innovation","Knowledge of genomics markets and technology","Senior Lecturer, MIT Sloan School of Management","Chief Innovation Officer of General Electric (GE)","CEO of GE Business Innovations","General Partner, Mohr Davidow Ventures","President and Board Member of Affymetrix, Inc.","Sr. Executive, Amersham Pharmacia Biotech","Board Chair at MIT The Engine"] | ["Compensation (Chair)"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALGN | Director | 65 | ["Chief Innovation Officer, GE","CEO, GE Ventures and Licensing","General Partner, Mohr Davidow Ventures","Director and President, Affymetrix","Illumina, Inc.","The Engine","KFF","Nevro Corporation","National Venture Capital Association","Pacific Biosciences, Inc.","Tech Interactive","Affymetrix"] | ["Technology Committee","Nominating and Governance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Director since 2019 Age: 65 Board Committees Compensation (Chair) Education B.S. in Biology from University of Puerto Rico M.S. in Biochemistry and Molecular Biology from Boston University Medical School Relevant Expertise Ms. Siegel s extensive experience leading and growing life science companies and driving innovation, as well as her knowledge of genomics markets and technology, greatly enhances the Board s understanding of our customers, technology roadmap, and the needs of our business. Career Highlights Senior Lecturer, MIT Sloan School of Management (since 2019) Chief Innovation Officer of General Electric (GE) and CEO of GE Business Innovations (GE s growth and innovation business), and CEO of GE Ventures (subsumed into Chief Innovation Officer role) (2012 2019) General Partner, Mohr Davidow Ventures (2006 2012) President and Board Member of Affymetrix, Inc. (1998 2006) Sr. Executive, Amersham Pharmacia Biotech (1990 1998), Final Role: President, Hoefer Business & VP, Business Development & Licensing (1996 1998) Public Board Service Nevro Corp. (since 2020) Align Technology, Inc. (since 2017) Pacific Biosciences of California, Inc. (2006 2012) Affymetrix, Inc. (2000 2006) Non-Public Board Service MIT s The Engine (since 2016; Chairman since 2020) Co-Chair, Stanford Medicine Board of Fellows (since 2017) Kaiser Family Foundation (since 2019) Mass General Brigham s Innovation Growth Board (since 2015) National Venture Capital Association, Board Member (2012 2016) Of Note Lifetime Achievement Award, Global Corporate Venturing (2020) and named to its Powerlist (2015 2019) Fortune s 34 Leaders Who are Changing Healthcare (2017) 100 of the Most Influential Women in Silicon Valley, Silicon Valley Business Journal (2006) Fierce Biotech s Top 10 Women in Medical Devices (2015) Henry Crown Fellow, The Aspen Institute Featured in Multipliers: How the Best Leaders Make Everyone Smarter Founding representative board member of NIH s National Center for Advancing Translational Sciences Served on President Obama s Precision Medicine Initiative Working Group, leading to the creation and launch of All of Us